Sweden Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook
Related Markets
Sweden veterinary active pharmaceutical ingredients manufacturing market highlights
- The Sweden veterinary active pharmaceutical ingredients manufacturing market generated a revenue of USD 82.3 million in 2024 and is expected to reach USD 161.6 million by 2033.
- The Sweden market is expected to grow at a CAGR of 7.8% from 2025 to 2033.
- In terms of segment, in house was the largest revenue generating service type in 2024.
- Contract Outsourcing is the most lucrative service type segment registering the fastest growth during the forecast period.
Veterinary active pharmaceutical ingredients manufacturing market data book summary
| Market revenue in 2024 | USD 82.3 million |
| Market revenue in 2033 | USD 161.6 million |
| Growth rate | 7.8% (CAGR from 2025 to 2033) |
| Largest segment | In house |
| Fastest growing segment | Contract Outsourcing |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | In House, Contract Outsourcing |
| Key market players worldwide | Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries |
Other key industry trends
- In terms of revenue, Sweden accounted for 0.9% of the global veterinary active pharmaceutical ingredients manufacturing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, UK veterinary active pharmaceutical ingredients manufacturing market is projected to lead the regional market in terms of revenue in 2033.
- France is the fastest growing regional market in Europe and is projected to reach USD 666.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Scope
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Excel Industries | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | http://www.excelind.co.in |
| Suanfarma Biotech | View profile | 251-500 | Alcobendas, Madrid, Spain, Europe | http://www.suanfarma.com |
| Vetpharma | View profile | 11-50 | Barcelona, Catalonia, Spain, Europe | https://vetpharma.com |
| Siflon Drugs & Pharmaceuticals | View profile | 11-50 | Hyderabad, Andhra Pradesh, India, Asia | https://siflonpharma.com |
| The Chem-Pro Group | View profile | 501-1000 | Mumbai, Maharashtra, India, Asia | https://www.chemprogroup.com |
| Ofichem Group | View profile | 51-100 | Ter Apel, Groningen, The Netherlands, Europe | https://ofichem.com |
| SeQuent Scientific | View profile | 1001-5000 | Bangalore, Karnataka, India, Asia | http://sequent.in |
| Menadiona | View profile | 51-100 | Barcelona, Catalonia, Spain, Europe | https://www.menadiona.com/ |
| Zoetis Inc Class A | View profile | 14100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | https://www.zoetis.com |
Sweden veterinary active pharmaceutical ingredients manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary active pharmaceutical ingredients manufacturing market will help companies and investors design strategic landscapes.
In house was the largest segment with a revenue share of 64.4% in 2024. Horizon Databook has segmented the Sweden veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2021 to 2033.
The veterinary API manufacturing market in Sweden is estimated to witness significant growth over the forecast period. The rising demand for pet healthcare services and the increasing pet ownership are some of the major factors strengthening market growth.
Moreover, the growing awareness regarding the importance of animal health & welfare also contributes to market growth. The increasing focus on animal disease control and the rising need for animal-derived protein products are estimated to boost veterinary API market demand.
Moreover, the rising pet ownership in Sweden is driving the growth in the veterinary API manufacturing market. As per a Swedish Board of Agriculture study, around 60% of households in Sweden own at least one pet, with cats & dogs being the most popular.
Reasons to subscribe to Sweden veterinary active pharmaceutical ingredients manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Sweden veterinary active pharmaceutical ingredients manufacturing market databook
-
Our clientele includes a mix of veterinary active pharmaceutical ingredients manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden veterinary active pharmaceutical ingredients manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Sweden veterinary active pharmaceutical ingredients manufacturing market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Sweden Contract Development - Veterinary Active Pharmaceutical Ingredients Manufacturing Market size, 2024 - 2033 (US$M)
Sweden Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
